ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $339,000 | -1.2% | 55,206 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $343,000 | +19.5% | 55,206 | +22.0% | 0.00% | 0.0% |
| Q1 2017 | $287,000 | +10.8% | 45,242 | -6.7% | 0.00% | 0.0% |
| Q4 2016 | $259,000 | -10.1% | 48,473 | -5.3% | 0.00% | 0.0% |
| Q3 2016 | $288,000 | +10.8% | 51,193 | +8.2% | 0.00% | 0.0% |
| Q2 2016 | $260,000 | -24.9% | 47,333 | +1.6% | 0.00% | -33.3% |
| Q1 2016 | $346,000 | -6.5% | 46,575 | +4.7% | 0.00% | -25.0% |
| Q4 2015 | $370,000 | -4.1% | 44,466 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $386,000 | +1329.6% | 42,823 | +326.1% | 0.00% | – |
| Q3 2014 | $27,000 | -34.1% | 10,050 | 0.0% | 0.00% | – |
| Q2 2014 | $41,000 | -33.9% | 10,050 | -25.5% | 0.00% | -100.0% |
| Q1 2014 | $62,000 | +5.1% | 13,489 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $59,000 | +11.3% | 13,489 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $53,000 | +112.0% | 13,489 | +12.5% | 0.00% | – |
| Q2 2013 | $25,000 | – | 11,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |